ARCH Venture Management as of Sept. 30, 2023
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 7 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eqrx | 52.4 | $81M | 36M | 2.22 | |
| Verve Therapeutics (VERV) | 17.3 | $27M | 2.0M | 13.26 | |
| Erasca (ERAS) | 14.1 | $22M | 11M | 1.97 | |
| Denali Therapeutics (DNLI) | 9.3 | $14M | 694k | 20.63 | |
| Gossamer Bio (GOSS) | 4.4 | $6.7M | 8.1M | 0.83 | |
| Unity Biotechnology (UBX) | 1.6 | $2.4M | 1.0M | 2.40 | |
| Singular Genomics Systems In | 0.9 | $1.4M | 3.8M | 0.38 |
